Insider · CIK 0002137706
Stephen M. Hahn
Files at FTH (Faeth Therapeutics, Inc.). First filing -, latest -.
In brief
Stephen M. Hahn files SEC Form 4 as director at FTH (Faeth Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen M. Hahn has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | FTH Faeth Therapeutics, Inc. | CConversion Common Stock | +44,763 | - | - | 44,763 | Jun 16, 2026 |
| Jun 12, 2026 | FTH Faeth Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 16, 2026 |
| Jun 15, 2026 | FTH Faeth Therapeutics, Inc. | CConversion Series B Preferred Stockderivative | -45 | - | - | 0 | Jun 16, 2026 |
Questions about Stephen M. Hahn
Answered from the filings on this page, as of the latest one.
Is Stephen M. Hahn buying or selling?
Stephen M. Hahn has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen M. Hahn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen M. Hahn has 0.
Where does Stephen M. Hahn file Form 4?
Stephen M. Hahn has filed Form 4 at FTH (Faeth Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.